BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 27353492)

  • 1. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation.
    Dasarathy J; Varghese R; Feldman A; Khiyami A; McCullough AJ; Dasarathy S
    J Nutr; 2017 Oct; 147(10):1938-1946. PubMed ID: 28814531
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial.
    Mansour A; Mohajeri-Tehrani MR; Samadi M; Qorbani M; Merat S; Adibi H; Poustchi H; Hekmatdoost A
    Nutr J; 2021 Apr; 20(1):35. PubMed ID: 33838673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease.
    Mahmoudi L; Asadi S; Al-Mousavi Z; Niknam R
    Clin Nutr; 2021 May; 40(5):2999-3005. PubMed ID: 33341312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Vitamin D Supplementation on Insulin Sensitivity and Insulin Secretion in Subjects With Type 2 Diabetes and Vitamin D Deficiency: A Randomized Controlled Trial.
    Gulseth HL; Wium C; Angel K; Eriksen EF; Birkeland KI
    Diabetes Care; 2017 Jul; 40(7):872-878. PubMed ID: 28468770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
    Ebrahimpour-Koujan S; Sohrabpour AA; Foroughi F; Alvandi E; Esmaillzadeh A
    Trials; 2019 Mar; 20(1):153. PubMed ID: 30832722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D
    Luger M; Kruschitz R; Kienbacher C; Traussnigg S; Langer FB; Prager G; Schindler K; Kallay E; Hoppichler F; Trauner M; Krebs M; Marculescu R; Ludvik B
    Obes Surg; 2017 May; 27(5):1196-1207. PubMed ID: 27837387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial.
    Dabbaghmanesh MH; Danafar F; Eshraghian A; Omrani GR
    Diabetes Metab Syndr; 2018 Jul; 12(4):513-517. PubMed ID: 29588137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial.
    Kampmann U; Mosekilde L; Juhl C; Moller N; Christensen B; Rejnmark L; Wamberg L; Orskov L
    Metabolism; 2014 Sep; 63(9):1115-24. PubMed ID: 25044176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
    Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial.
    Luger M; Kruschitz R; Marculescu R; Haslacher H; Hoppichler F; Kallay E; Kienbacher C; Klammer C; Kral M; Langer F; Luger E; Prager G; Trauner M; Traussnigg S; Würger T; Schindler K; Ludvik B
    Trials; 2015 Aug; 16():328. PubMed ID: 26242295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
    Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
    Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol.
    Wicklow B; Wittmeier K; T' Jong GW; McGavock J; Robert M; Duhamel T; Dolinsky VW
    Biochem Cell Biol; 2015 Oct; 93(5):522-30. PubMed ID: 26305052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA; Khan DA; Ijaz A; Khan S
    Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altilix
    Castellino G; Nikolic D; Magán-Fernández A; Malfa GA; Chianetta R; Patti AM; Amato A; Montalto G; Toth PP; Banach M; Cicero AFG; Rizzo M
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31731527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes.
    Barchetta I; Angelico F; Del Ben M; Di Martino M; Cimini FA; Bertoccini L; Polimeni L; Catalano C; Fraioli A; Del Vescovo R; Morini S; Baroni MG; Cavallo MG
    Clin Sci (Lond); 2016 Oct; 130(19):1753-62. PubMed ID: 27458255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin D supplementation on various parameters in non-alcoholic fatty liver disease patients.
    Hussain M; Iqbal J; Malik SA; Waheed A; Shabnum S; Akhtar L; Saeed H
    Pak J Pharm Sci; 2019 May; 32(3 Special):1343-1348. PubMed ID: 31551213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
    Courbebaisse M; Alberti C; Colas S; Prié D; Souberbielle JC; Treluyer JM; Thervet E
    Trials; 2014 Nov; 15():430. PubMed ID: 25376735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D-deficient non-Western immigrants in the Netherlands: a randomized placebo-controlled trial.
    Oosterwerff MM; Eekhoff EM; Van Schoor NM; Boeke AJ; Nanayakkara P; Meijnen R; Knol DL; Kramer MH; Lips P
    Am J Clin Nutr; 2014 Jul; 100(1):152-60. PubMed ID: 24898240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial.
    Della Corte C; Carpino G; De Vito R; De Stefanis C; Alisi A; Cianfarani S; Overi D; Mosca A; Stronati L; Cucchiara S; Raponi M; Gaudio E; Byrne CD; Nobili V
    PLoS One; 2016; 11(12):e0168216. PubMed ID: 27977757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.